Covidien plc Introduces HALO90 ULTRA Ablation Catheter for Treatment of Barrett's Esophagus

Published: May 17, 2012

SUNNYVALE, Calif.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the launch of the HALO90 ULTRA Ablation Catheter, the latest addition to the HALO family of catheters for the endoscopic treatment of Barrett’s esophagus.

Back to news